301 related articles for article (PubMed ID: 32993629)
1. Retargeting azithromycin analogues to have dual-modality antimalarial activity.
Burns AL; Sleebs BE; Siddiqui G; De Paoli AE; Anderson D; Liffner B; Harvey R; Beeson JG; Creek DJ; Goodman CD; McFadden GI; Wilson DW
BMC Biol; 2020 Sep; 18(1):133. PubMed ID: 32993629
[TBL] [Abstract][Full Text] [Related]
2. Targeting malaria parasites with novel derivatives of azithromycin.
Burns AL; Sleebs BE; Gancheva M; McLean KT; Siddiqui G; Venter H; Beeson JG; O'Handley R; Creek DJ; Ma S; Frölich S; Goodman CD; McFadden GI; Wilson DW
Front Cell Infect Microbiol; 2022; 12():1063407. PubMed ID: 36530422
[TBL] [Abstract][Full Text] [Related]
3. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
Wilson DW; Goodman CD; Sleebs BE; Weiss GE; de Jong NW; Angrisano F; Langer C; Baum J; Crabb BS; Gilson PR; McFadden GI; Beeson JG
BMC Biol; 2015 Jul; 13():52. PubMed ID: 26187647
[TBL] [Abstract][Full Text] [Related]
4. Chemobiosynthesis of new antimalarial macrolides.
Goodman CD; Useglio M; Peirú S; Labadie GR; McFadden GI; Rodríguez E; Gramajo H
Antimicrob Agents Chemother; 2013 Feb; 57(2):907-13. PubMed ID: 23208707
[TBL] [Abstract][Full Text] [Related]
5. On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
Edgar RCS; Malcolm TR; Siddiqui G; Giannangelo C; Counihan NA; Challis M; Duffy S; Chowdhury M; Marfurt J; Dans M; Wirjanata G; Noviyanti R; Daware K; Suraweera CD; Price RN; Wittlin S; Avery VM; Drinkwater N; Charman SA; Creek DJ; de Koning-Ward TF; Scammells PJ; McGowan S
mBio; 2024 Jun; 15(6):e0096624. PubMed ID: 38717141
[TBL] [Abstract][Full Text] [Related]
6. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.
Biswas S
J Postgrad Med; 2001; 47(4):240-3. PubMed ID: 11832638
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species.
Wittlin S; Ekland E; Craft JC; Lotharius J; Bathurst I; Fidock DA; Fernandes P
Antimicrob Agents Chemother; 2012 Feb; 56(2):703-7. PubMed ID: 22083475
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy and limit of detection of ten malaria parasite lactate dehydrogenase-based rapid tests for
Tan AF; Sakam SSB; Rajahram GS; William T; Abd Rachman Isnadi MF; Daim S; Barber BE; Kho S; Sutherland CJ; Anstey NM; Yerlikaya S; van Schalkwyk DA; Grigg MJ
Front Cell Infect Microbiol; 2022; 12():1023219. PubMed ID: 36325471
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
Sidhu AB; Sun Q; Nkrumah LJ; Dunne MW; Sacchettini JC; Fidock DA
J Biol Chem; 2007 Jan; 282(4):2494-504. PubMed ID: 17110371
[TBL] [Abstract][Full Text] [Related]
13. Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of
de Carvalho LP; Groeger-Otero S; Kreidenweiss A; Kremsner PG; Mordmüller B; Held J
Front Cell Infect Microbiol; 2021; 11():802294. PubMed ID: 35096650
[TBL] [Abstract][Full Text] [Related]
14. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
15. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
16. UK malaria treatment guidelines 2016.
Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
[TBL] [Abstract][Full Text] [Related]
17. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
[TBL] [Abstract][Full Text] [Related]
18. MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Penna-Coutinho J; da Silva Araújo M; Campos Aguiar AC; Sá PM; Rios CT; Medeiros JF; Pereira DB; Boechat N; Krettli AU
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():150-155. PubMed ID: 34637981
[TBL] [Abstract][Full Text] [Related]
19. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
Bustamante C; Batista CN; Zalis M
Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
